Patent · US Active

BRD4 inhibitor compound in solid form and preparation method therefor and use thereof

US12344620B2 · kind B2 · utility

0Cited by

4References

15Claims

0Family size

Assignee

CSPC ZHONGQI PHARMACEUTICAL TECHNOLOGY (SHIJIAZHUANG) CO., LTD. · CN

Inventors

Chunli Shen · Shanghai, CN
Yong Liu · Shanghai, CN
Huanyu Bian · Shanghai, CN
Chengde Wu · Shanghai, CN
Jiahu Wu · Shanghai, CN

Key dates

Filing date	Mar 23, 2020
Grant date	Jul 1, 2025
Priority date	—
Expiry date	Sep 22, 2042

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07B2200/13
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Disclosed are a solid form and a crystal form of a compound represented by formula (I) used as a BRD4 inhibitor, a preparation method therefor, and an application thereof in the preparation of a medicine for treating BRD4-related diseases. (I).

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.